Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Vir Biotechnology Q4 2025 Earnings Call - Astellas Deal and Phase I VIR-5500 Data De-risk and Accelerate Prostate Cancer Push
Vir Biotechnology used its Q4 2025 update to do two things at once, and do them loudly. The company struck a landmark collaboration with Astellas that injects upfront capital, shares development costs...
- Vir announced a strategic collaboration with Astellas for VIR-5500, a dual-masked PRO-XTEN PSMA-targeting T-cell engager, to co-develop and co-commercialize globally.
- Financial terms: $315 million upfront consideration split as $240 million cash and $75 million equity at $10.36 per share, plus a $20 million manufacturing tech-transfer milestone and up to $1.37 billion in additional development, regulatory, and ex-US commercial milestones, for total potential consideration of $1.7 billion.
- Commercial split: U.S. profits shared 50/50, Vir holds an option to co-promote in the U.S., Astellas receives exclusive ex-U.S. rights, Vir gets tiered double-digit royalties and ex-US milestones.
- +11 more takeaways
U.S. Global Investors Q2 2026 Earnings Call - Gold momentum, ETF inflows and buybacks offset a one-time tax hit
Management pitched a clear narrative: gold and thematic ETFs are driving asset and revenue momentum, the balance sheet is healthy, and the company is using opportunistic share buybacks plus a high sha...
- Assets under management rose to approximately $1.7 billion, with average AUM for the period $1.48 billion.
- Operating revenues for the quarter were $2.5 million, up 13% year over year driven by AUM gains, especially in equity mutual funds.
- Pre-tax income reported was $535,000, and quarterly EBITDA per share improved to $0.04 in December.
- +13 more takeaways
Backblaze Q4 2025 Earnings Call - Adjusted Free Cash Flow Positive as Company Bets on NeoClouds with a $15M+ TCV Win
Backblaze closed 2025 with a milestone quarter, reporting Q4 revenue of $37.8 million, adjusted EBITDA margin of 28%, and the company’s first Adjusted Free Cash Flow positive quarter as a public compa...
- Q4 revenue was $37.8 million, in line with guidance; full-year total company revenue grew 14% year-over-year.
- Backblaze reported its first Adjusted Free Cash Flow positive quarter as a public company, $4 million in Q4 representing an 11% margin.
- Q4 adjusted EBITDA margin reached 28%, roughly double the prior year, with some outperformance driven by non-recurring items such as variable compensation alignment and office restructuring savings.
- +16 more takeaways
Allison Transmission Q4 2025 Earnings Call - Dana Off-Highway Deal Closed, $120M Synergies Promised, 2026 Guide Built Conservatively
Allison closed the acquisition of Dana’s Off-Highway Drive & Motion Systems on January 1, creating a two‑segment company and a significantly expanded global footprint. Management is bullish on long‑te...
- Allison completed the acquisition of Dana Incorporated’s Off‑Highway Drive & Motion Systems business effective January 1, creating a combined company with roughly 14,000 employees across 25 countries.
- The combined company will operate as two business units: Allison Transmission led by Fred Bohley, and Allison Off‑Highway Drive & Motion Systems led by Craig Price, both reporting to CEO David Graziosi.
- Full‑year 2025 revenue for the legacy Allison Transmission business declined 7% year‑over‑year, while adjusted EBITDA margin expanded 140 basis points to 37.5%.
- +16 more takeaways
DMC Global Fourth Quarter 2025 Earnings Call - Tariffs and High Rates Crush Margins Despite Big Debt Paydown
DMC reported a quarter of shrinking top line and squeezed margins, even as management delivered a striking cleanup of the balance sheet. Consolidated sales fell 6% year over year to $143.5 million, ad...
- Net debt fell to $18.7 million at year end, a 67% reduction from end of 2024, driven by strong cash flow and debt paydown; cash on hand roughly $32 million.
- Consolidated Q4 sales declined 6% year over year to $143.5 million, reflecting weakness across the energy and construction end markets.
- Adjusted EBITDA attributable to DMC was negative $1.6 million in Q4, which included about $7 million of discrete accounts receivable and inventory write-offs at DynaEnergetics.
- +12 more takeaways
Summit Therapeutics Q4 2025 Earnings Call - Squamous cohort enrollment complete, interim PFS readout set for Q2 2026
Summit used this quarter to push timelines and broaden the ivonesimab story. The company completed screening for the squamous cohort of the pivotal HARMONi-3 study and has added an interim PFS analysi...
- HARMONi-3 squamous cohort: screening completed, last patient to be randomized within weeks, and an interim PFS analysis is planned for Q2 2026; overall survival will be immature at that interim look.
- HARMONi-3 non-squamous cohort: enrollment expected to complete in H2 2026; final PFS events anticipated by H1 2027.
- Regulatory and BLA status: FDA accepted Summit’s BLA for the HARMONi (EGFR-mutant post-TKI) indication; PDUFA target date is November 14, 2026. FDA has indicated a statistically significant OS benefit is necessary in that setting.
- +11 more takeaways
MediaAlpha Inc Q4 2025 Earnings Call - P&C Surge and AI Tailwinds Drive Open Marketplace Momentum
MediaAlpha closed 2025 with clear momentum: P&C insurance accelerated sharply, AI-driven traffic and platform optimization lifted click volumes and take rates, and management is steering the business ...
- Company milestones for 2025: $2.0 billion Transaction Value, $1.0 billion revenue, and $100 million Adjusted EBITDA, all firsts for the firm.
- Q4 2025 Transaction Value was $613 million, up 23% year-over-year; P&C grew 38% YoY, while the health vertical declined 40% YoY.
- Q4 revenue was $291 million, down 3% YoY as reported, but up 9% YoY excluding Under-65 health insurance; Under-65 health revenue fell to about $7 million in 2025 from $41 million in 2024.
- +12 more takeaways
Keysight Technologies Fiscal Q1 2026 Earnings Call - AI-driven wireline surge powers revenue and lifts FY outlook above 20%
Keysight delivered a clean, broad-based beat in fiscal Q1, driven by an unexpected surge in wireline orders tied to AI infrastructure and optical interconnect demand. Revenue of $1.6 billion and EPS o...
- Q1 revenue $1.6 billion, up 23% reported, with acquisitions contributing +8 points and currency +1; core (organic) growth was 14%.
- Q1 orders $1.645 billion, up 30% reported and up 22% on a core basis, signaling strong demand momentum.
- Gross margin expanded to 66.7%, up 90 basis points, helped by favorable product mix and higher-margin revenues from recent acquisitions.
- +16 more takeaways
Cannae Holdings Q4 2025 Earnings Call - Accelerating pivot to sports and entertainment while monetizing non-core assets
Cannae used the quarter to double down on a strategic pivot toward sports and entertainment, moving from public securities toward proprietary private investments the team says it can actively drive. M...
- Strategic pivot announced: Cannae will concentrate primarily on sports and entertainment-related assets where it believes it has a differentiated competitive advantage.
- Major portfolio actions in 2025 included the sale of Dun & Bradstreet to Clearlake for total proceeds of $630 million to Cannae.
- Shareholder returns were significant: $323 million of stock repurchases in 2025, equal to 17.4 million shares or roughly 28% of shares outstanding, and a 25% quarterly dividend increase to $0.15 per quarter; $30 million in dividends paid in 2025.
- +13 more takeaways
SI-BONE Q4 2025 Earnings Call - Record $200.9M Revenue and First Full-Year Positive Adjusted EBITDA
SI-BONE closed 2025 with a clean line of sight: record revenue, healthier margins, and an innovation pipeline that management says will drive a multi-year growth cycle. The company reported $200.9 mil...
- Record 2025 revenue of $200.9 million, up 20.2% year over year, and Q4 revenue of $56.3 million, up 15%.
- Company delivered first full year of positive Adjusted EBITDA, $8.9 million for 2025, with Q4 Adjusted EBITDA of $5.1 million and a 9.1% margin. Free cash flow turned positive in Q4, about $0.5 million.
- Strong profitability metrics, gross margin roughly 79% in Q4 and 79.6% for the year, about 200 basis points above original 2025 guidance. Management expects gross margin of about 78% in 2026.
- +10 more takeaways